Uncommon BCR-ABL kinase domain mutations in kinase inhibitor-resistant chronic myelogenous leukemia and Ph+ acute lymphoblastic leukemia show high rates of regression, suggesting weak selective effects
- Dan Jones(corresponding author),
- Su S. Chen,
- Elias Jabbour,
- Mary Beth Rios,
- Hagop Kantarjian,
- University of Texas Health Science Center at Houston
Scholary Output:
Contribution to journal
Letter
Peer-review
Open access
Publication Information
Output type
Scholary Output:
Contribution to journal
Letter
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 5428-5429 (2 pages)Journal (Volume, Issue Number)
Blood (Volume 115, Issue 26)Publication milestones
- Published - 07/01/2010
Publication status
Published - 07/01/2010
ISSN
0006-4971Publication IDs
- Scopus: 77955863869
- PubMed: 20595523
- ORCID: /0000-0002-8636-1071/work/68810990
Publication metrics
Metrics
Fractional count
1
Fractional count
0.17
Fractional count
5
Fractional count
0.83
Fractional count
1
Fractional count
1
SciVal
FWCI
0.34
SciVal
Author count
6
SciVal
citations
8
SciVal
Paper percentile
59
PlumX, opens in new tab
Citation count
11
Captures
14
Funding Details
FunderFunding number
NCI
P30CA016672